| Full text | |
| Author(s): |
Rached, Marici R.
[1]
;
Coelho, Veronica
[2, 3, 4]
;
Marin, Maria Lucia C.
[2, 3]
;
Pincerato, Kstja
[5]
;
Fujita, Andre
[6]
;
Kalil, Jorge E.
[2, 1, 3, 4]
;
Abrao, Mauricio S.
[7, 8]
Total Authors: 7
|
| Affiliation: | [1] Univ Sao Paulo, Sch Med, Clin Immunol & Allergy Div, Sao Paulo, SP - Brazil
[2] Univ Sao Paulo, Heart Inst InCor, Sch Med, Sao Paulo - Brazil
[3] Univ Sao Paulo, Sch Med, Histocompatibil & Cellular Immunol Lab, LIM 19, Sao Paulo, SP - Brazil
[4] Univ Sao Paulo, Inst Invest Immunol, Natl Inst Sci & Technol Iii INCT, Sao Paulo, SP - Brazil
[5] Univ Sao Paulo, Pathol Div, Sch Med, Clin Hosp, Sao Paulo, SP - Brazil
[6] Univ Paulo, Inst Math & Stat, Sao Paulo, SP - Brazil
[7] Univ Sao Paulo, Hosp Clin HCFMUSP, Gynecol Div, Endometriosis Sect, Fac Med, Sao Paulo, SP - Brazil
[8] BP, Gynecol Div, Sao Paulo, SP - Brazil
Total Affiliations: 8
|
| Document type: | Journal article |
| Source: | EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY; v. 235, p. 36-41, APR 2019. |
| Web of Science Citations: | 1 |
| Abstract | |
Objective: To assess whether the HLA-G immunomodulatory protein is potentially involved in the pathophysiology of endometriosis or disease progression. Study design: Cross-sectional observational study of 227 women who underwent laparoscopy, being 146 for endometriosis excision and 81 for elective tubal ligation (control group). Soluble HLA-G (sHLA-G) levels in the serum and peritoneal fluid (PF), as well as the HLA-G protein expression in matched eutopic and ectopic endometrium of women with and without endometriosis were evaluated by ELISA and immunohistochemistry assays, respectively. Women with endometriosis were separated into groups according to the initial (I/II, n=60) and advanced (III/IV, n=86) stages of disease. sHLA-G measurement was performed only in women with matched serum and PF samples in both the control (CTRL; n=77) and endometriosis (EDT; I-II, n=60; n=83) groups. HLA-G protein expression was evaluated in 26 women with deep endometriosis (I-II, n=12; III-IV, n=14) and 22 controls. Results: Higher concentrations of sHLA-G (P=0.013) in the serum but not in the PF were observed in women with advanced endometriosis compared to the control group. In situ expression of HLA-G protein was also higher in ectopic (P=0.018) but not in eutopic endometrium of women with advanced endometriosis compared to control group. Conclusion: Our findings suggest that HLA-G upregulation in advanced stages may contribute to the state of immunosuppression in endometriosis as disease progresses. (C) 2019 Elsevier B.V. All rights reserved. (AU) | |
| FAPESP's process: | 10/10338-0 - Endometriosis: molecular bases of immune response |
| Grantee: | Maurício Simões Abrão |
| Support Opportunities: | Research Projects - Thematic Grants |